Lv31
230 积分 2024-07-09 加入
Fármacos basados en GLP-1: mecanismos implicados en el tratamiento de la obesidad
5小时前
求助中
Gewichtsreduktion mit Inkretinmimetika – Chancen und Risiken
5小时前
已完结
Depression and suicide/self-injury signals for weight loss medications: A disproportionality analysis of semaglutide, liraglutide, and tirzepatide in FAERS database
5小时前
已关闭
FRI-453 Proteomics reveals the effect of liraglutide in enhancing fatty acid metabolism and reducing fibrosis in metabolic dysfunction-associated steatotic liver disease
14天前
已关闭
Role of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) Conditions
14天前
已关闭
Efficacy and Safety of Pharmacological Interventions in Managing Cardiometabolic Risk Factors in Youth Living with Overweight and Obesity: A Systematic Review and Network Meta‐Analysis
14天前
已关闭
Role of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) Conditions
27天前
已关闭
Role of Glucagon-Like Peptide-1 and Glucose-Dependent Insulinotropic Polypeptide/Glucagon-Like Peptide-1 Receptor Agonists in Management of Cardiovascular-Kidney-Metabolic (CKM) Conditions
28天前
已关闭
FRI-453 Proteomics reveals the effect of liraglutide in enhancing fatty acid metabolism and reducing fibrosis in metabolic dysfunction-associated steatotic liver disease
28天前
已关闭
Glucagon-like peptide-1 receptor agonists in neurodegenerative diseases: Promises and challenges
28天前
已关闭
皖公网安备34019202002308
